Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2017

Open Access 01-12-2017 | Research article

Prevalence of undiagnosed type 2 diabetes in patients admitted with acute coronary syndrome: the utility of easily reproducible screening methods

Authors: Muhammad A. Karamat, Umar Y. Raja, Susan E. Manley, Alan Jones, Wasim Hanif, Abd A. Tahrani

Published in: BMC Endocrine Disorders | Issue 1/2017

Login to get access

Abstract

Background

Despite the recognition of the importance of diagnosing dysglycaemia in patients with acute coronary syndrome (ACS) there remains a lack of consensus on the best screening modality. Our primary aims were to determine the prevalence of undiagnosed dysglycaemia and to compare the OGTT and HbA1c criteria for diagnosis of T2DM in patients admitted to hospital with ACS at baseline and at 3-months. We also aimed to investigate the role of a screening algorithm and a predictor score to define glucose tolerance in this population.

Methods

A prospective study in which patients admitted with ACS to two UK teaching hospitals were assessed at baseline and 3 months follow-up.

Results

The prevalence of diabetes at baseline was 20% and 16% based on OGTT and HbA1c criteria respectively. Forty three (43) % of the patients with T2DM based on OGTT would have been missed by the HbA1c criteria at baseline. Our screening algorithm identified 87% of patients with T2DM diagnosed with OGTT. Diabetes Predictor score had better sensitivity (>80%) and negative predictive value (>90%) compared to HbA1c criteria. Two thirds of participants with IGS and a third with T2DM changed their glycaemic status at 3 months.

Conclusions

Only 48% of the patients admitted with ACS had normo-glycaemia based on OGTT. OGTT and HbA1c identified two different populations of patients with dysglycaemia with the HbA1c criteria missing almost half the patients with T2DM based on OGTT. Compared to HbA1c criteria our diabetes algorithm and diabetes predictor score had a better correlation with OGTT criteria.
Literature
1.
go back to reference Ever D Grech, David R Ramsdale ABC of interventional cardiology. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. BMJ. 2003;326:1259–61. Ever D Grech, David R Ramsdale ABC of interventional cardiology. Acute coronary syndrome: unstable angina and non-ST segment elevation myocardial infarction. BMJ. 2003;326:1259–61.
2.
go back to reference Paxinos G, Demosthenes G. Katritsis current therapy of Non-ST-elevation acute coronary syndromes. Hellenic J Cardiol. 2012;53:63–71.PubMed Paxinos G, Demosthenes G. Katritsis current therapy of Non-ST-elevation acute coronary syndromes. Hellenic J Cardiol. 2012;53:63–71.PubMed
4.
go back to reference Fonseca V, Desouza C, Asnani S. Jialal I Non-traditional risk factors for cardiovascular disease in diabetes. Endocr Rev. 2004;25(1):153–75.CrossRefPubMed Fonseca V, Desouza C, Asnani S. Jialal I Non-traditional risk factors for cardiovascular disease in diabetes. Endocr Rev. 2004;25(1):153–75.CrossRefPubMed
5.
go back to reference Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1–7.CrossRefPubMed Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41:1–7.CrossRefPubMed
6.
go back to reference Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.CrossRefPubMed Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8.CrossRefPubMed
7.
go back to reference Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111(30):78–86. Kosiborod M, Rathore SS, Inzucchi SE, et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation. 2005;111(30):78–86.
8.
go back to reference de Mulder M, Cornel JH, van der Ploeg T, et al. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients,irrespective of the initially applied reperfusion strategy. Am Heart J. 2010;160:412–19.CrossRefPubMed de Mulder M, Cornel JH, van der Ploeg T, et al. Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients,irrespective of the initially applied reperfusion strategy. Am Heart J. 2010;160:412–19.CrossRefPubMed
9.
go back to reference Bolk J, van der Ploeg T, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207–14.CrossRefPubMed Bolk J, van der Ploeg T, Cornel JH, et al. Impaired glucose metabolism predicts mortality after a myocardial infarction. Int J Cardiol. 2001;79:207–14.CrossRefPubMed
10.
go back to reference Wallander M, et al. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice. Diabetes Care. 2008;31(1):36–8.CrossRefPubMed Wallander M, et al. Oral glucose tolerance test: a reliable tool for early detection of glucose abnormalities in patients with acute myocardial infarction in clinical practice. Diabetes Care. 2008;31(1):36–8.CrossRefPubMed
11.
12.
go back to reference Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140–4.CrossRefPubMed Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet. 2002;359:2140–4.CrossRefPubMed
13.
go back to reference Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The euro heart survey on diabetes and the heart. Eur Heart J. 2004;25:1880–90.CrossRefPubMed Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The euro heart survey on diabetes and the heart. Eur Heart J. 2004;25:1880–90.CrossRefPubMed
14.
go back to reference Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in china: the china heart survey. Eur Heart J. 2006;27:2573–9.CrossRefPubMed Hu DY, Pan CY, Yu JM. The relationship between coronary artery disease and abnormal glucose regulation in china: the china heart survey. Eur Heart J. 2006;27:2573–9.CrossRefPubMed
15.
go back to reference Andersen GO, Eritsland J, Aasheim A, Neuburger J, Knudsen EC, Mangschau A. Impaired glucose tolerance in patients with acute myocardial infarction. Tidsskr Nor Laegeforen. 2006;126:2264–7.PubMed Andersen GO, Eritsland J, Aasheim A, Neuburger J, Knudsen EC, Mangschau A. Impaired glucose tolerance in patients with acute myocardial infarction. Tidsskr Nor Laegeforen. 2006;126:2264–7.PubMed
16.
go back to reference Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group Sep 12 1998 The Lancet, Vol. 352 No. 9131 pp837-853 Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) UK Prospective Diabetes Study (UKPDS) Group Sep 12 1998 The Lancet, Vol. 352 No. 9131 pp837-853
17.
go back to reference Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) Group Sep 12 1998 The Lancet, Vol. 352 No. 9131 pp 854-86 Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) UK Prospective Diabetes Study (UKPDS) Group Sep 12 1998 The Lancet, Vol. 352 No. 9131 pp 854-86
18.
go back to reference The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med. 1993 Sep 30; 329 (14):977-86. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group N Engl J Med. 1993 Sep 30; 329 (14):977-86.
19.
go back to reference Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the european society of cardiology (ESC) and of the european association for the study of diabetes (EASD). Eur Heart J. 2007;28:88–136.CrossRefPubMed Ryden L, Standl E, Bartnik M, et al. Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the european society of cardiology (ESC) and of the european association for the study of diabetes (EASD). Eur Heart J. 2007;28:88–136.CrossRefPubMed
20.
go back to reference Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the american heart association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation. 2008;117:1610–9.CrossRefPubMed Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T, et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the american heart association diabetes committee of the council on nutrition, physical activity, and metabolism. Circulation. 2008;117:1610–9.CrossRefPubMed
21.
go back to reference Zhao YT, Weng CL, Chen ML, et al. Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials. Heart. 2010;96:1622–6.CrossRefPubMed Zhao YT, Weng CL, Chen ML, et al. Comparison of glucose-insulin-potassium and insulin-glucose as adjunctive therapy in acute myocardial infarction: a contemporary meta-analysis of randomised controlled trials. Heart. 2010;96:1622–6.CrossRefPubMed
22.
go back to reference de Mulder M, Oemrawsingh RM, Stam F, Boersma E, Umans VA. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome. Heart. 2012;98(1):37–41.CrossRefPubMed de Mulder M, Oemrawsingh RM, Stam F, Boersma E, Umans VA. Comparison of diagnostic criteria to detect undiagnosed diabetes in hyperglycaemic patients with acute coronary syndrome. Heart. 2012;98(1):37–41.CrossRefPubMed
23.
go back to reference de Mulder M, Oemrawsingh RM, Stam F, et al. Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey. Crit Pathw Cardiol. 2009;8:66–70.CrossRefPubMed de Mulder M, Oemrawsingh RM, Stam F, et al. Current management of hyperglycemia in acute coronary syndromes: a national Dutch survey. Crit Pathw Cardiol. 2009;8:66–70.CrossRefPubMed
24.
go back to reference Alberti KG, et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed Alberti KG, et al. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–53.CrossRefPubMed
25.
go back to reference Gillett MJ.International Expert Committee report on the role of A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34. Gillett MJ.International Expert Committee report on the role of A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327–34.
26.
go back to reference Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SCL, Smith JM. Validation of an algorithm combining haemoglobin A1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabetic Medicine. 2009;26(2):115–21.CrossRefPubMed Manley SE, Sikaris KA, Lu ZX, Nightingale PG, Stratton IM, Round RA, Baskar V, Gough SCL, Smith JM. Validation of an algorithm combining haemoglobin A1c and fasting plasma glucose for diagnosis of diabetes mellitus in UK and Australian populations. Diabetic Medicine. 2009;26(2):115–21.CrossRefPubMed
27.
go back to reference Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired fasting glucose to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701–10.CrossRefPubMedPubMedCentral Edelstein SL, Knowler WC, Bain RP, et al. Predictors of progression from impaired fasting glucose to NIDDM: an analysis of six prospective studies. Diabetes. 1997;46:701–10.CrossRefPubMedPubMedCentral
28.
go back to reference Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R. Age as independent determinant of glucose tolerance. Diabetes. 1991;40:44–51.CrossRefPubMed Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R. Age as independent determinant of glucose tolerance. Diabetes. 1991;40:44–51.CrossRefPubMed
29.
go back to reference de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a dutch population:the hoorn study. JAMA. 2001;285:2109–13.CrossRefPubMed de Vegt F, Dekker JM, Jager A, et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a dutch population:the hoorn study. JAMA. 2001;285:2109–13.CrossRefPubMed
Metadata
Title
Prevalence of undiagnosed type 2 diabetes in patients admitted with acute coronary syndrome: the utility of easily reproducible screening methods
Authors
Muhammad A. Karamat
Umar Y. Raja
Susan E. Manley
Alan Jones
Wasim Hanif
Abd A. Tahrani
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2017
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-017-0153-y

Other articles of this Issue 1/2017

BMC Endocrine Disorders 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.